Attached files

file filename
EX-99.1 - EXHIBIT 99.1 PRESS RELEASE - LIBERATOR MEDICAL HOLDINGS, INC.f8k012214_ex99z1.htm


UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549



FORM 8-K



CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934



Date of Report (Date of earliest event reported):  January 21, 2014



LIBERATOR MEDICAL HOLDINGS, INC.

(Exact name of registrant as specified in its charter)



NEVADA

000-05663

87-0267292

(State or other jurisdiction

(Commission

(IRS Employer

Of incorporation)

File Number)

Identification Number)



2979 SE Gran Park Way, Stuart, Florida 34997

(Address of Principal Executive Offices)



(772) 287-2414

(Registrant’s telephone number, including area code)



   

(Former name or former address, if changed since last report.)






Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:


      . Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


      . Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


      . Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


      . Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))








ITEM 8.01

OTHER EVENTS


On January 21, 2014, Liberator Medical Holdings, Inc. (the “Company”), issued a press release.  A copy of the press release is attached as Exhibit 99.1.


The information under the caption, “Item 8.01 – Other Events,” including information in any related exhibits, is being furnished to the Securities and Exchange Commission and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section.  This information shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.


ITEM 9.01

FINANCIAL STATEMENTS AND EXHIBITS


(d)

Exhibits


Exhibit No.

Description

 

 

99.1

Press release issued by Liberator Medical Holdings, Inc., on January 21, 2014.





2




SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.



LIBERATOR MEDICAL HOLDINGS, INC.

                        Registrant



Dated: January 21, 2014

 /s/ Mark A. Libratore                              

Mark A. Libratore,

President and Chief Executive Officer


3